
Nucleosides and Nucleotides p. 1393 - 1402 (1995)
Update date:2022-08-03
Topics:
Mourier
Trabaud
Graciet
Simon
Niddam
Faury
Charvet
Camplo
Chermann
Kraus
New peptide-nucleosides which consist of an anti-RT nucleoside and anti- protease peptide moieties, were designed in order to investigate their anti- HIV-1 properties. The synthesis of these new analogues was achieved using BOP coupling reagent which avoided the protection and deprotection steps of the 5'-OH group of the nucleoside part. These new compounds tested on MT4 infected cells show no increase in anti-HIV activities compared to that of the component pieces. Interestingly we found that the 5'-(tert- butyldiphenyl)silyl analogues show anti-HIV activities equivalent to that of the 5'-free OH corresponding compounds. This result suggests a possible interaction of these compounds at a non-substrate binding site of the reverse transcriptase.
View Morewebsite:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Weifang Adde Economic And Trade Co.,LTD.
Contact:86-536-8885548
Address:Room 1402,Wanda Plaza B Block,No.958,Yuanfei Road,Kuiwen District
Qingdao XinYongAn Chemicals Co., Ltd
Contact:+86-532-81107967
Address:Chengyang dual-port industrial park by the sea,Qingdao
Oren Hydrocarbons (Qingdao) Co., Ltd.
Contact:+86-532-68607667-801
Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Chiral Quest (Suzhou) Company Ltd
website:http://www.chiralquest.com
Contact:+86-0512-62956066
Address:B1/9, 218 Xinghu Street, Suzhou Industrial Park
Doi:10.1039/c3nj00050h
(2013)Doi:10.1039/C6SC04014D
(2017)Doi:10.1021/jm400390r
(2013)Doi:10.1039/c3ob40911b
(2013)Doi:10.1039/c5ra02279g
(2015)Doi:10.1039/a805268i
(1998)